華森製藥(002907.SZ):取得藥品生產許可證 涉生產地址、生產範圍和日常監管機構的變更
格隆匯12月13日丨華森製藥(002907.SZ)公佈,公司於2019年12月12日收到重慶市藥品監督管理局頒發的《藥品生產許可證》(許可證編號:渝20150018),此次主要涉生產地址、生產範圍和日常監管機構的變更。變更內容如下:
(一)在生產地址重慶市榮昌區工業園區上增加生產範圍:原料藥(阿魏酸鈉、甘草酸二銨、聚維酮碘);(二)增加生產地址和生產範圍:重慶市榮昌區昌州街道板橋路143號:散劑,顆粒劑,軟膠囊劑,凍乾粉針劑,粉針劑,片劑,硬膠囊劑;(三)日常監管機構由榮昌區分局變更為重慶市藥品監督管理局檢查二局。其他內容不變
此次《藥品生產許可證》涉及原生產基地(第一至四期生產基地,地址:重慶市榮昌區工業園區)增加原料藥的生產範圍,進一步豐富和完善了公司原料藥的產品結構,有利於公司逐步實現原料藥、製劑一體化戰略;此次《藥品生產許可證》涉及新增第五期新建GMP生產基地項目(“五期項目”,地址:重慶市榮昌區昌州街道板橋路143號)的生產地址和生產範圍,有利於公司加快五期項目產品轉移工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.